TRIZI

TZP-DUAL is a synthetic 39-amino acid modified peptide utilized for the investigation of dual receptor signaling pathways. This reagent is a specialized incretin mimetic designed to investigate the agonism of the glucose-dependent insulinotropic polypeptide (GIP) receptor and associated metabolic signaling networks. Research applications focus on the study of nutrient-stimulated hormone secretion, the interrogation of pancreatic beta-cell signaling, and the investigation of lipid metabolism markers within in vitro metabolic research models.